Seòmar agus comataidhean

Our best and final estimate of the number of reverse vending machines (RVMs) that will be required to operate Scotland’s Deposit Return Scheme (DRS) is 3,021, as set out in Table 2 of the amended final Business and Regulatory Impact Assessment (BRIA) published on 15 December 2021. At the time of drafting the amended final BRIA, Circularity Scotland Ltd (CSL) confirmed that this matched their estimate.

We have had no further discussions with CSL regarding any estimated numbers of RVMs since that time and do not recognise the figure of around 5,000. Although it is entirely appropriate for CSL to continue to update its own assumptions regarding key parameters for DRS, our best and final estimate prior to implementation remains unchanged and we have no intention to further revisit the amended final BRIA.

The powers required to legislate in respect of company acquisition and ownership are reserved to the UK Parliament and, as such, the Scottish Government does not have the power to take action in this area. In addition recent legislative change in the UK via the National Security and Investment Act enables an increased screening of acquisitions in certain sectors on grounds, for example, of national security. This reflects similar change in EU legislation.

The Scottish Government and Enterprise Agencies therefore aim to work with businesses in Scotland, domestic and overseas owned, to ensure Scottish operations are not only secured here but opportunities for growth are pursued. Scotland has a highly supportive eco-system for early stage and high growth businesses with potential to scale. In a UK context Scotland is recognised by the Scale Up Institute as having a particularly supportive business eco-system for ambitious Scottish companies, with our Enterprise Agencies at the centre of a network based upon collaboration between public, private, third sector organisations and academic partners.

In support of this approach both our Inward Investment and Global Capital Investment Plans place maximum emphasis on securing good quality investment into Scotland aligning with our values as a nation and delivering our net zero economy supported by good green jobs. We will therefore continue to work closely with those Scottish and overseas-owned businesses and organisations with whom those values most closely align.

As at the week beginning 11 April 2022, over 6300 non-hospitalised individuals had received COVID-19 treatments (oral antivirals or monoclonal antibody treatment) in Scotland since 22 December 2021.

Adults and children (aged 12 years and above) are eligible to be assessed for their suitability for new COVID-19 treatments if they:

? have symptoms of coronavirus that started in the last 5 days with no signs of clinical recovery;

? are a member of one of the patient groups considered at high risk from coronavirus and with a clinical condition prioritised for treatment; and

? coronavirus is confirmed by a positive lateral flow device (LFD) or PCR test.

Some COVID-19 positive individuals who meet the eligibility criteria will decide not to receive antiviral treatments, or may be unable to, for example due to other medications they are taking.

The information on those who were eligible for treatment and who received it within five days and those who did not receive it within five days is not held centrally.

As set out in the answer to S6W-07830 on 29 April 2022, we have had no further discussions with Circularity Scotland Ltd regarding any estimated numbers of reverse vending machines since the publication of the amended final Business and Regulatory Impact Assessment for our Deposit Return Scheme, and do not recognise the figure of around 5,000.

. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

( a) The information requested is not held centrally.

(b) The Scottish Government recognises that accurate data on long COVID prevalence and symptoms is needed to forecast and plan for the need for healthcare services arising from long COVID. Public Health Scotland will lead on surveillance of long COVID. It is currently anticipated that this surveillance will be undertaken via the EAVE II study, in collaboration with the University of Edinburgh ( About EAVE II | The University of Edinburgh ). Funded by the Medical Research Council, the EAVE II study has used a pseudonymised patient dataset to track the COVID-19 pandemic across Scotland. In a separate project funded by the Chief Scientist Office, the EAVE II dataset will be used to create a tool to identify people at greatest risk of developing long COVID. The findings will in due course provide information about the number of people diagnosed with long COVID and their use of health services, including among residents of care homes.

The powers required to legislate in respect of company acquisition and ownership are reserved to the UK Parliament and, as such, the Scottish Government does not have the power to take action in this area. In addition recent legislative change in the UK via the National Security and Investment Act enables an increased screening of acquisitions on grounds, for example, of national security. This reflects similar change in EU legislation.

These legislative mechanisms notwithstanding, company acquisition remains a commercial decision to be undertaken by two private entities. The Scottish Government and Enterprise Agencies therefore aim to work with businesses in Scotland, domestic and overseas owned, to ensure Scottish operations are not only secured here but opportunities for growth are pursued.

Scottish Enterprise research suggests acquisition can be an important route for companies with growth potential to achieve their ambitions; either Scottish companies who acquire other businesses or Scottish companies acquired by businesses from other parts of the UK and internationally. This is not unique to Scotland and is a feature of similar economies.

In addition both our Inward Investment and Global Capital Investment Plans place maximum emphasis in supporting good quality investment into Scotland aligning with our values as a nation and delivering our net zero economy supported by good green jobs. We will therefore continue to work closely with those Scottish and overseas-owned businesses and organisations with whom those values most closely align.

Over the next few years each project will go through project development and consenting processes, respond to geographical and technological requirements, and find a route to market. There are several variables to be considered across these processes, including aspects such as grid connection and the impact of offshore wind developments on various environmental receptors.

To add to my response of 31 March 2022, it is not possible at this stage to predict how long each of the 17 ScotWind projects awarded lease options will take to pass through the project development and consenting process, achieve connections to the onshore grid network and subsequently to undergo construction. For each project this is a complex and multi-faceted process involving a number of variables, including the iterative review of offshore wind planning assumptions, impacts arising from environmental assessments, consultative processes, investment decisions with regard to supporting supply chain activity, success in securing power supply agreements though the Contracts for Difference regime, and potential challenges to be addressed in design and construction with regard to physical conditions and the application of innovative floating wind technologies being pioneered at GW scale in a number of projects. These variables are dynamic and are capable of affecting the size and nature of projects as well as the speed at which they will progress. Their impact cannot be predicted with accuracy at this stage.

Forward planning with regard to potential generating capacity, which may be expected from ScotWind and other offshore renewables developments, informs our thinking and is continually reviewed. This type of forward planning will next be reflected in the Government’s Draft Energy Strategy and Just Transition Plan due to be published for consultation this autumn.

Providing consistent high quality personalised care for people living in care homes is a key priority for health and care services in Scotland. The Scottish Government is clear that anyone living in a care home who would benefit from access to NHS services should receive it. This includes access to care and support in relation to symptoms caused by long-term effects of COVID-19, where such services are clinically assessed to be in the best interest for their care.

The Scottish Government is currently working with people, families, the care home sector and other stakeholders to develop a framework for adults living in care homes. The Framework will seek to examine how the health and care of people living in care homes should be optimised, supported, and delivered, and to ensure that they receive the right care from health care professions at the right time and have access to the same level of involvement, choice and support for their health and wellbeing as if they were living in their own home. It will also aim to enhance the health of people living within a care home, improving the way we assess, monitor and respond to enduring and changing health and care needs through working with health and care professionals, health and social care partnerships and care home providers.

In addition, we have awarded the Care Inspectorate £95,000 to enable them to build on the learning from the Care About Physical Activity (CAPA) programme. The project will work across cares homes, care at home, housing support and day services for adults, with a focus on engaging people in physical and mental activities and movement in order to positively affect health and wellbeing.

A directors letter (DL) was issued by Chief Nursing Officer on 31 March regarding the de-escalation of enhanced IPC measures as we now observe that harms associated with reduced elective services within NHS Scotland are now outweighing COVID-19 harms. The DL outlined the removal of guidance on physical distancing and car sharing as well as changes to the types of COVID-19 tests that are available for patient use.

NSS ARHAI Scotland are also undertaking a gap analysis across the current Scottish Winter (21/22), Respiratory Infections in Health and Care Settings Addendum and the National Infection, Prevention and Control Manual (NIPCM). This analysis will highlight which COVID-19 specific aspects of the winter respiratory guidance, require to be retained and carried over into the NIPCM. This work is envisaged to be completed in early May.

Any decision by the Republic of Ireland to exclude glass from their deposit return scheme (DRS) is a matter for them.

The Full Business Case Stage 1 for Scotland’s Deposit Return Scheme (DRS), published on 8 May 2019 (pp36-37), considered the costs and benefits of including glass within the scheme and concluded that glass should be included due to the substantial environmental and economic benefits. The Scottish Government remains fully committed to this position, which is also that taken by the Welsh Government.